Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
OSENVELT 120 mg/1.7 ml Inj Lös 120 mg 1 Durchstf
Drug
Osenvelt, solution injectable
07.16.1. – cytostatics
HAM – Human medicine
LSINJ – Solution for injection
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
8/19/2025
8/18/2030
Dosage strength
Osenvelt 120 mg/1.7 ml (70 mg/ml), solution injectable
Métastases osseuses issues de turneurs solides; tumeurs à cellules géantes de l'os
01
Z – approved
Package
7680701960013
In trade from / since 2/20/2026
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component
120 mg denosumabum
acidum aceticum glaciale
natrii acetas trihydricus
0.5 mg natrium
79.9 mg sorbitolum
polysorbatum 20
aqua ad iniectabile
natrii acetas trihydricus
0.5 mg natrium
79.9 mg sorbitolum
polysorbatum 20
aqua ad iniectabile
Authorisation holder
7601001402683
IQONE HEALTHCARE SWITZERLAND
route de Suisse 160-162
1290 Versoix (GE)
route de Suisse 160-162
1290 Versoix (GE)
Date of revision of the text
2/1/2026
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.